Tiziana Life Sciences Announces Presentations on Intranasal Foralumab at the “Preserving the Brain” Scientific Conference and Exhibit at the Fondazione Prada in Milan
Retrieved on:
Wednesday, September 28, 2022
Exhibition, University, Autoimmunity, Safety, IV, COVID-19, Cytokine, Fondazione Prada, Hospital, Progress MS-06, Neurodegeneration, NEW, Poster, Immunotherapy, MS, Patient, Crohn's disease, Neurology, Technology, Cinema, Mab, BWH, Degenerative disease, Fondazione Child, SPMS, Research, Inflammation, GLOBE, State observer, Pharmaceutical industry, Medical device, Regulatory T cell, Brain, Foralumab, Podium, Brigham
Preserving the Brain is a scientific forum and exhibit on neurodegenerative diseases as part of the Human Brains neuroscience project held in Fondazione Prada in Milan, Italy.
Key Points:
- Preserving the Brain is a scientific forum and exhibit on neurodegenerative diseases as part of the Human Brains neuroscience project held in Fondazione Prada in Milan, Italy.
- The aim of this event is to stimulate an open and critical exchange between international scientists and experts on neurodegenerative diseases.
- I am absolutely thrilled that foralumab was highlighted at the Fondazione Pradas Preserving the Brain international forum, commented Gabriele Cerrone, Executive Chairman and interim Chief Executive Officer of Tiziana Life Sciences.
- The pivotal moment of "Preserving the Brain" will be the scientific conference held on 6 and7 October 2022, at Fondazione Prada's Cinema inMilan.